News: NXS Next Science Sees Revenue To Be Constrained In Q2, page-4

Apparently you were mate. They give no revenue guidance and for a good reason, they don’t have any to give. Either your buying the technology or your buying the revenue and two years later we continue to get glossy pieces written by the companies leadership that talk about how great there pipeline is and how hard they are working. How are the current partnerships working? I will tell you, apparently not good as demonstrated. So when do you expect them to turn in discernible and consistent global revenue growth and some profit? Another two years from now? I believe in the technology, I just don’t believe that NXS has the right leadership in place to commercialize these products. I see value in owning the stock again - just not at these levels as NXS’s value is in the IP - not in this leadership team. As always, do your due diligence.